Nexus Biopharma

Nexus Biopharma

Nexus BioPharma is developing a treatment for obesity and the symptoms of pre-diabetes. Nexus’ first product is a small molecule drug that activates cellular regulatory pathways that regulate obesity/diabetes to increase energy expenditure.

Area of focus: 
Cardiovascular and Metabolism
Commencement date: 
02/01/2017

Share